Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma

PLoS One. 2018 Feb 14;13(2):e0191865. doi: 10.1371/journal.pone.0191865. eCollection 2018.

Abstract

The interaction between cancer cells and the cancer stroma plays a crucial role in tumor progression and metastasis in diverse malignancies, including oral cancer. However, the mechanism underlying this interaction remains incompletely elucidated. Here, to investigate the interaction between oral cancer cells and fibroblasts, which are major cellular components of the tumor stroma, we conducted an in vitro study by using human oral squamous cell carcinoma (OSCC) cell lines and normal human dermal fibroblasts (NHDFs). The results of transwell assays revealed that the migration and invasion of 2 OSCC cell lines, HO1-N-1 and HSC3, were markedly stimulated upon coculturing with NHDFs. To investigate the factors that promote tumor invasion, we isolated NHDFs from cocultures prepared with HO1-N-1 cells and performed microarray analysis. Among the various genes that were upregulated, we identified the gene encoding leukemia inhibitory factor (LIF), and we focused on LIF in further analyses. We confirmed that all OSCC-derived conditioned media potently upregulated LIF expression in NHDFs, and the results of our transwell analysis demonstrated that NHDF-induced OSCC migration and invasion were inhibited by LIF-neutralizing antibodies. Furthermore, immunohistochemical analysis of patient samples revealed that in 44 out of 112 OSCC cases, LIF was expressed in the tumor stroma, particularly in cancer-associated fibroblasts (CAFs), and, notably, clinicopathological analyses confirmed that LIF expression in CAFs was significantly correlated with increased depth of tumor invasion. Collectively, our results suggest that OSCC stimulates fibroblasts to produce LIF, which, in turn, participates in cancer-cell invasion. Our finding offers a potential therapeutic strategy targeting the cancer stroma for the treatment of OSCC patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / pathology*
  • Cell Line, Tumor
  • Coculture Techniques
  • Culture Media, Conditioned
  • Fibroblasts / metabolism
  • Humans
  • Leukemia Inhibitory Factor / physiology*
  • Mouth Neoplasms / pathology*
  • Neoplasm Invasiveness*

Substances

  • Culture Media, Conditioned
  • Leukemia Inhibitory Factor

Grants and funding

This work was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp/english/e-grants/), Grant-in-Aid for Young Scientists (B), 16K20410 to KK; Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp/english/e-grants/), Grant-in-Aid for Scientific Research (A), 25253098 to AY. The Iwadare Scholarship Foundation supported YO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.